Tower Research Capital (TRC)’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Tower Research Capital (TRC)’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,316	Closed	-$9.98K	–	6326
2023 Q4	$9.98K	Buy	8,316 +1,969	+31%	+$2.13K	﹤0.01%	4314
2023 Q3	$5.47K	Sell	6,347 -261	-4%	-$286	﹤0.01%	4712
2023 Q2	$7.93K	Buy	+6,608	New	+$33.1K	﹤0.01%	4503
2023 Q1	–	Sell	-1,408	Closed	-$11K	–	6507
2022 Q4	$11K	Sell	1,408 -2,556	-64%	-$16K	﹤0.01%	3915
2022 Q3	$19K	Buy	3,964 +2,917	+279%	+$18.3K	﹤0.01%	3995
2022 Q2	$6K	Sell	1,047 -982	-48%	-$3.37K	﹤0.01%	4993
2022 Q1	$10K	Buy	2,029 +1,110	+121%	+$8.9K	﹤0.01%	4389
2021 Q4	$11K	Sell	919 -57	-6%	-$814	﹤0.01%	4489
2021 Q3	$15K	Buy	976 +26	+3%	+$443	﹤0.01%	4011
2021 Q2	$15K	Buy	+950	New	+$16.6K	﹤0.01%	4151

Tower Research Capital (TRC)'s RAIN Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 8,316 shares — an estimated $9.98K sold.

Tower Research Capital (TRC) first reported a position in RAIN in Q2 2021 and held it in 10 quarters. The position peaked at $19K in Q3 2022. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Tower Research Capital (TRC) reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 8,316 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $9.98K.
Tower Research Capital (TRC) first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Tower Research Capital (TRC)'s Rain Oncology Inc. Common Stock position peaked at $19K in Q3 2022.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.